| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/02/1999 | WO1999043809A2 Protease-activated receptor 4 and uses thereof |
| 09/02/1999 | WO1999043693A1 36 human secreted proteins |
| 09/02/1999 | WO1999043680A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | WO1999043672A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | WO1999043664A1 Heterocyclic diarylmethylene derivatives, methods of preparing them and their uses in therapeutics |
| 09/02/1999 | WO1999043654A2 Inhibitors of phospholipase enzymes |
| 09/02/1999 | WO1999043651A2 Inhibitors of phospholipase enzymes |
| 09/02/1999 | WO1999043642A1 Phenylalanine derivatives as inhibitors of alpha4 integrins |
| 09/02/1999 | WO1999043344A2 Matrix protein compositions for wound healing |
| 09/02/1999 | WO1999024460A3 Dipeptide nitriles |
| 09/02/1999 | CA2640994A1 Enamel matrix protein composition for preventing or treating infection |
| 09/02/1999 | CA2322163A1 Inhibitors of phospholipase a2 |
| 09/02/1999 | CA2322162A1 Inhibitors of phospholipase enzymes |
| 09/02/1999 | CA2322161A1 Inhibitors of phospholipase enzymes |
| 09/02/1999 | CA2321970A1 36 human secreted proteins |
| 09/02/1999 | CA2321559A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 09/02/1999 | CA2321178A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | CA2321142A1 Protease-activated receptor 4 and uses thereof |
| 09/02/1999 | CA2320829A1 Heterocyclic diarylmethylene derivatives, methods of preparing them and their uses in therapeutics |
| 09/01/1999 | EP0939127A2 Humanized immunoglobulins and their production and use |
| 09/01/1999 | EP0939121A2 TNF-binding proteins |
| 09/01/1999 | EP0938500A1 INTERLEUKIN-1beta-CONVERTING ENZYME (ICE) INHIBITING PEPTIDES |
| 09/01/1999 | EP0938496A1 Heptapeptide oxytocin analogues |
| 09/01/1999 | EP0938482A1 5-substituted and 5,5-disubstituted-3,4-dihydroxy-2(5h)-furanones and methods of use therefor |
| 09/01/1999 | EP0938477A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| 09/01/1999 | EP0938471A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/01/1999 | EP0938334A1 Improved method of treating immune cell mediated systemic diseases |
| 09/01/1999 | EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 09/01/1999 | EP0938305A2 Method of alleviating pain by means of combining tramadol with an nmda antagonist |
| 09/01/1999 | EP0700301B1 Peptides and compounds that bind to elam-1 |
| 09/01/1999 | CN1227607A Humanized immunoglobulin reactive with alpha 4 beta 7 integrin |
| 09/01/1999 | CN1227563A Modified oligosaccharides |
| 09/01/1999 | CN1227554A Substituted 6,5-hetero-bicyclic derivatives |
| 09/01/1999 | CN1227547A Arylalkanoyl pyridazines |
| 09/01/1999 | CN1227542A N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
| 09/01/1999 | CN1227540A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 09/01/1999 | CN1227501A Long-acting drugs and pharmaceutical compositions comprising them |
| 09/01/1999 | CN1044912C Thio-substituted cyclic phosphonate compounds, and its pharmaceutical compositions and use |
| 09/01/1999 | CN1044905C Anellated dihydropyridines and its producing method and medicinal composition comprising them |
| 08/31/1999 | US5945539 Enzyme inhibitor |
| 08/31/1999 | US5945446 Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 08/31/1999 | US5945440 Indolocarbazole imides and the use thereof |
| 08/31/1999 | US5945433 Humans and veterinary science |
| 08/31/1999 | US5945416 Method for treating pain |
| 08/31/1999 | US5945408 Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors |
| 08/31/1999 | US5945398 In a hydrophilic carrier comprising propylene glycol,esterification product of vegetable oil triglyceride and polyalkalene glycol polyol and polyoxyethylene hydrogenated castor oil; free-flowing, clear, transparent |
| 08/31/1999 | US5945310 DNA encoding members of the IL-1 family, IL-1 delta |
| 08/31/1999 | US5945302 Nucleotide sequences that code for proteins for use in recombinant technology, induce production of cytokines, activate cell differentiation, stimulate and suppress immune responses, and therapy for autoimmune diseases |
| 08/31/1999 | US5945106 A concentrated extract of reduced nordihydroguairetic acid containing larrea tridentate plant material, and ascorbic acid, a corticosteroid, a nonsteroid anti-inflammatory, an antiinflammatory fatty acid, p-antagonsist, and an anesthetic |
| 08/31/1999 | CA2145835C Hydroxamic acid derivatives with tricyclic substitution |
| 08/27/1999 | CA2242794A1 2,4-bis[(4-aminidino)phenyl]furans as anti-pneumocystis carini agents |
| 08/26/1999 | WO1999042584A1 Apoptosis inducing molecule ii and methods of use |
| 08/26/1999 | WO1999042579A2 Caf1-related protein |
| 08/26/1999 | WO1999042568A1 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
| 08/26/1999 | WO1999042485A1 Mucilage, a g-protein-coupled receptor |
| 08/26/1999 | WO1999042443A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| 08/26/1999 | WO1999042436A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 08/26/1999 | WO1999042133A1 Inhibitors of complement activation |
| 08/26/1999 | WO1999042130A1 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| 08/26/1999 | WO1999042124A1 Liquid crystal forms of cyclosporin |
| 08/26/1999 | WO1999042105A1 Epimorphian compound and its use |
| 08/26/1999 | WO1999042101A1 Dietary control of arachidonic acid metabolism |
| 08/26/1999 | WO1999042075A2 Antibodies against human cd40 |
| 08/26/1999 | WO1999033989A3 Rantes mutants and therapeutic applications thereof |
| 08/26/1999 | WO1999026909A3 Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors |
| 08/26/1999 | WO1999012944A3 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
| 08/26/1999 | WO1998030696A8 Secreted proteins and polynucleotides encoding them |
| 08/26/1999 | CA2321973A1 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| 08/26/1999 | CA2321186A1 Apoptosis inducing molecule ii and methods of use |
| 08/26/1999 | CA2321165A1 Antibodies against human cd40 |
| 08/26/1999 | CA2321140A1 Inhibitors of complement activation |
| 08/26/1999 | CA2320632A1 Caf1-related protein |
| 08/26/1999 | CA2320469A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 08/26/1999 | CA2318959A1 Epimorphian compound and its use |
| 08/25/1999 | EP0937777A2 GABA receptors and their uses |
| 08/25/1999 | EP0937722A1 Benzimidazole derivatives as cyclooxygenase-2 inhibitors |
| 08/25/1999 | EP0937064A1 Substituted oximes derivatives useful as neurokinin antagonists |
| 08/25/1999 | EP0937042A1 Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 08/25/1999 | EP0937038A1 Vitamin d analogues |
| 08/25/1999 | EP0937036A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors |
| 08/25/1999 | EP0937032A1 Substituted gamma aminobutyric acids as pharmaceutical agents |
| 08/25/1999 | EP0936918A1 Combination therapy for treatment of arthritic diseases |
| 08/25/1999 | EP0936912A1 Inhibitors of cysteine protease |
| 08/25/1999 | EP0936909A1 Pharmaceutical composition for treating viral diseases |
| 08/25/1999 | EP0650483B1 (3R,4R)-$g(D)?6 -TETRAHYDROCANNABINOL-7-OIC ACIDS |
| 08/25/1999 | EP0612321B1 Pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity |
| 08/25/1999 | EP0237545B2 Production of pluripotent granulocyte colony-stimulating factor |
| 08/25/1999 | CN1226892A Compounds and compositions for treating diseases associated with tryptase activity |
| 08/25/1999 | CN1226830A Egg anti-inflammatory composition, method of isolation and use |
| 08/25/1999 | CN1226824A Tramadol multiple unit formulations |
| 08/24/1999 | US5942535 a!-Annelated pyrrole derivatives and pharmaceutical use thereof |
| 08/24/1999 | US5942523 Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools |
| 08/24/1999 | US5942507 Furan nitrone compounds |
| 08/24/1999 | US5942503 Use of Epinastine for the treatment of pain |
| 08/24/1999 | US5942419 RsbW-1 encoding nucleic acids |
| 08/24/1999 | US5942405 Identifying compounds which inhibit complement receptors by mixing cells expressing surface complement receptors with a labeled compound capable of binding receptor and determining if compound inhibits interactions by signal generation |
| 08/24/1999 | US5942228 An amino acid sequence protein for the manufacture of complex carbohydrates and as a target for screening of small molecule antagonists of enzyme activity; treating diseases of cellular fucosylation |
| 08/24/1999 | CA2176974C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 08/20/1999 | CA2249653A1 Novel compounds |
| 08/19/1999 | WO1999041402A2 Targeting of genetic vaccine vectors |